FDA issued a Warning Letter to Acella Pharmaceuticals, LLC on 8/14/2020 as a result of this inspection.
FDA investigators audited the Acella Pharmaceuticals - Alpharetta, GA, United States facility and issued inspectional observations (via FDA 483) on 07 Jan 2020.
Product details
- Category: Human Drugs
- Inspection end: 07 Jan 2020
- Location: Alpharetta, United States
- FEI: 3006691461
